Riten Kumar: DOACs Effectiveness in Pediatric Cancer-Associated Thrombosis
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
”Direct oral anticoagulants are efficacious when appropriately used in children with cancer associated thrombosis – though the rate of clinically relevant bleeding in this cohort was higher than what’s been reported in the pediatric randomized trials……..
Most CRNM bleeds occurred in the setting of thrombocytopenia.”
Title: Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers
Authors: Riten Kumar, Emily Drake, Joseph Stanek, Nicholas Yeager, Lynda M. Vrooman, Lewis B. Silverman, Vilmarie Rodriguez
Read the Full Article on Research and Practice in Thrombosis and Haemostasis
Find more posts featuring Riten Kumar on Hemostasis Today.
-
Feb 16, 2026, 14:30Pat Garcia-Gonzalez։ Love as an Essential Part of the Healing Journey
-
Feb 16, 2026, 14:19Erwin Loh։ Sleep-Aligned Fasting as an Important Regulator of Cardiometabolic Health
-
Feb 16, 2026, 13:56Chokri Ben Lamine: Evans Syndrome Key Clinical Insights
-
Feb 16, 2026, 13:51Adela Castro: 2025 EULAR Guidelines Key Updates in Lupus Nephritis
-
Feb 16, 2026, 13:50Rosa Hart: Stop Waiting For A Seat And Start Shaping The Table
-
Feb 16, 2026, 13:49Harprit Singh: India’s Silent Transfusion Gap – What Policymakers Need to Know in 2026
-
Feb 16, 2026, 13:46A Conversation on Gene Therapy in Hemophilia B – Irish Haemophilia Society
-
Feb 16, 2026, 13:45Nathan Connell Speaks on Gender Diversity In Haemostasis Care at EAHAD 2026
-
Feb 16, 2026, 13:40David McIntosh: Concrete Performance Targets for Rare Disease Patients